Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk...

Published on 22 Nov 2024 on Investor's Business Daily

In a recent interview with Fox News, RFK Jr...rather than pharmaceuticals. He also called out...

Read the rest of the article

Start tracking your investments with Statfolio

In a recent interview with Fox News, RFK Jr...rather than pharmaceuticals. He also called out...

Investor's Business Daily 22 Nov 2024

This means that PFE's earnings estimate revision activity has been more impressive, so investors ...

Zacks · via Yahoo Finance 21 Nov 2024

Kennedy isn’t a fan of Novo Nordisk’s weight-loss treatment Ozempic, which costs the government t...

Barrons.com 21 Nov 2024

Here's why they view Eli Lilly (LLY -1.80%), Novo Nordisk (NVO -3.04%), and Vertex Pharmaceutical...

The Motley Fool 18 Nov 2024

Ozempic works by mimicking a hormone that regulates blood sugar and suppresses appetite. In...

Quartz 18 Nov 2024

↘️ Applied Materials (AMAT): Shares fell 8% after the semiconductor-equipment company posted a...

The Wall Street Journal 15 Nov 2024

Polen Capital, an investment management company, released its “Polen Global Growth Strategy”...

Insider Monkey · via Yahoo Finance 15 Nov 2024

The stock's average trading price was $1,112.86 during the quarter, with a -30.47% return over th...

GuruFocus.com · via Yahoo Finance 14 Nov 2024

Novo Nordisk A/S (NYSE:NVO), a global healthcare company specializing in diabetes care and obesit...

Investing.com 13 Nov 2024

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Disruptive analytics’ Substack by Ma...

Insider Monkey · via Yahoo Finance 12 Nov 2024